Efficacy and Safety Results from a Phase 3 Study of Biosimilar Candidate ABP 710 in Subjects with Moderate to Severe RA Genovese, M., Sanchez-Burson, J., Balazs, E., Everding, A., Oh, M., Fanjiang, G., Cohen, S. WILEY. 2019

View details for Web of Science ID 000507466900521